MediWound Ltd is a biotechnology business based in the US. MediWound shares (MDWD) are listed on the NASDAQ and all prices are listed in US Dollars. MediWound employs 75 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in MediWound
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MDWD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
MediWound stock price (NASDAQ: MDWD)Use our graph to track the performance of MDWD stocks over time.
MediWound shares at a glance
|Latest market close||$3.40|
|52-week range||$2.90 - $6.07|
|50-day moving average||$4.44|
|200-day moving average||$4.75|
|Wall St. target price||$7.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.24|
Buy MediWound shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy MediWound stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
MediWound price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-17.07%|
|3 months (2021-04-30)||-24.94%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is MediWound under- or over-valued?
Valuing MediWound stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MediWound's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MediWound's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.2 million.
The EBITDA is a measure of a MediWound's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$23.2 million|
|Gross profit TTM||$7.5 million|
|Return on assets TTM||-15.39%|
|Return on equity TTM||-109.19%|
|Market capitalisation||$103.5 million|
TTM: trailing 12 months
Shorting MediWound shares
There are currently 479,706 MediWound shares held short by investors – that's known as MediWound's "short interest". This figure is 52.9% up from 313,731 last month.
There are a few different ways that this level of interest in shorting MediWound shares can be evaluated.
MediWound's "short interest ratio" (SIR)
MediWound's "short interest ratio" (SIR) is the quantity of MediWound shares currently shorted divided by the average quantity of MediWound shares traded daily (recently around 705450). MediWound's SIR currently stands at 0.68. In other words for every 100,000 MediWound shares traded daily on the market, roughly 680 shares are currently held short.
However MediWound's short interest can also be evaluated against the total number of MediWound shares, or, against the total number of tradable MediWound shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MediWound's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 MediWound shares in existence, roughly 20 shares are currently held short) or 0.0285% of the tradable shares (for every 100,000 tradable MediWound shares, roughly 29 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MediWound.
Find out more about how you can short MediWound stock.
MediWound share dividends
We're not expecting MediWound to pay a dividend over the next 12 months.
MediWound share price volatility
Over the last 12 months, MediWound's shares have ranged in value from as little as $2.9 up to $6.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MediWound's is 1.5321. This would suggest that MediWound's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MediWound Ltd. , a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MWPC005, a topically applied biological drug candidate that is in Phase I/II clinical trial for the treatment of non-melanoma skin cancers; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. .
Stocks similar to MediWound
MediWound in the news
MediWound: Disappointing Thus Far But Still A Strong Buy
Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know
MediWound: Adjusting My Strategy After NexoBrid CRL
Frequently asked questionsWhat percentage of MediWound is owned by insiders or institutions?
Currently 42.805% of MediWound shares are held by insiders and 20.363% by institutions. How many people work for MediWound?
Latest data suggests 75 work at MediWound. When does the fiscal year end for MediWound?
MediWound's fiscal year ends in December. Where is MediWound based?
MediWound's address is: 42 Hayarkon Street, Yavne, Israel, 8122745 What is MediWound's ISIN number?
MediWound's international securities identification number is: IL0011316309 What is MediWound's CUSIP number?
MediWound's Committee on Uniform Securities Identification Procedures number is: M68830104
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert